| |
| |
| Exchange: |
Nasdaq National Market |
| Security
Type: |
Common |
| Shares
Out: |
136,480,000 |
| Market
Cap: |
4.07(B) |
| Last
Volume: |
503,160 |
Avg
Vol: |
501,775 |
| 52
Week Range: |
$26.23 - $39.94 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Drugs |
| Level
III Sector: |
Drug Related Products |
|
Member Indexes:
|
| |
S&P COMPOSITE 1500 |
|
NASDAQ BIOTECHNOLOGY |
| |
NASDAQ COMPOSITE |
|
S&P 400 MIDCAP |
| |
NASDAQ NNM COMPOSITE |
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile Perrigo is a provider of over-the-counter health and wellness solutions that can be self-managed. Co.'s segments are as follows: Consumer Self-Care Americas, which is focused primarily on the sale of self-care products in categories including upper respiratory, pain and sleep-aids, digestive health, nutrition, vitamins, minerals and supplements; Consumer Self-Care International, which develops, manufactures, markets, and distributes European consumer self-care brands in the upper respiratory, pain and sleep-aids, digestive health, vitamins, minerals and supplements; and Prescription Pharmaceuticals, which develops, manufactures, and markets a portfolio of generic prescription drugs.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
0 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
0 |
0 |
0 |
0 |
| Total Buy Transactions |
0 |
0 |
0 |
0 |
| Total Shares Sold |
0 |
0 |
0 |
0 |
| Total Sell Value |
$0 |
$0 |
$0 |
$0 |
| Total People Sold |
0 |
0 |
0 |
0 |
| Total Sell Transactions |
0 |
0 |
0 |
0 |
| End Date |
2024-02-18 |
2023-11-17 |
2023-05-19 |
2022-05-19 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Yu Louis |
Senior VP Global Quality |
• – – |
2011-08-29 |
4 |
S |
$93.50 |
$585,065 |
D/D |
(6,239) |
5,490 |
|
- |
|
| Yu Louis |
Senior VP Global Quality |
• – – |
2011-08-29 |
4 |
OE |
$30.06 |
$112,782 |
D/D |
3,436 |
7,286 |
|
- |
|
| Jandernoa Michael J |
Director |
– • – |
2011-08-26 |
4 |
GD |
$0.00 |
$0 |
I/I |
3,342 |
206,470 |
|
- |
|
| Lebel Refael |
EVP & GM Perrigo Israel |
• – – |
2011-08-26 |
4 |
S |
$92.07 |
$1,009,039 |
D/D |
(10,959) |
8,886 |
|
- |
|
| Lebel Refael |
EVP & GM Perrigo Israel |
• – – |
2011-08-26 |
4 |
OE |
$30.06 |
$350,248 |
D/D |
10,959 |
19,845 |
|
- |
|
| Brown Judy L |
Executive VP & CFO |
• – – |
2011-08-26 |
4 |
AS |
$89.40 |
$795,186 |
D/D |
(8,864) |
18,133 |
|
- |
|
| Hendrickson John T |
EVP Global Operations & Supply |
• – – |
2011-08-26 |
4 |
S |
$89.07 |
$404,462 |
D/D |
(4,541) |
0 |
|
- |
|
| Kingma Todd W |
Executive VP, General Counsel |
• – – |
2011-08-26 |
4 |
AS |
$88.65 |
$538,152 |
D/D |
(6,000) |
21,738 |
|
- |
|
| Farrington Thomas |
Senior VP and CIO |
• – – |
2011-08-26 |
4 |
AS |
$88.86 |
$254,510 |
D/D |
(2,834) |
1,903 |
|
- |
|
| Shah Jatin |
Sr VP & Chief Scientific Offic |
• – – |
2011-08-25 |
4 |
D |
$90.94 |
$209,708 |
D/D |
(2,306) |
5,372 |
|
- |
|
| Shah Jatin |
Sr VP & Chief Scientific Offic |
• – – |
2011-08-25 |
4 |
OE |
$90.94 |
$472,979 |
D/D |
5,201 |
6,303 |
|
- |
|
| Kochan Sharon |
Executive VP U.S. Generics |
• – – |
2011-08-25 |
4 |
D |
$90.94 |
$268,910 |
D/D |
(2,957) |
6,429 |
|
- |
|
| Kochan Sharon |
Executive VP U.S. Generics |
• – – |
2011-08-25 |
4 |
OE |
$90.94 |
$581,561 |
D/D |
6,395 |
7,571 |
|
- |
|
| Lebel Refael |
EVP & GM Perrigo Israel |
• – – |
2011-08-25 |
4 |
OE |
$90.94 |
$808,093 |
D/D |
8,886 |
8,886 |
|
- |
|
| Yu Louis |
Senior VP Global Quality |
• – – |
2011-08-25 |
4 |
D |
$90.94 |
$113,675 |
D/D |
(1,250) |
8,293 |
|
- |
|
| Yu Louis |
Senior VP Global Quality |
• – – |
2011-08-25 |
4 |
OE |
$90.94 |
$368,580 |
D/D |
4,053 |
8,776 |
|
- |
|
| Stewart Michael Robert |
Sr. VP Global Human Resources |
• – – |
2011-08-25 |
4 |
D |
$90.94 |
$108,128 |
D/D |
(1,189) |
3,532 |
|
- |
|
| Stewart Michael Robert |
Sr. VP Global Human Resources |
• – – |
2011-08-25 |
4 |
OE |
$90.94 |
$350,937 |
D/D |
3,859 |
3,991 |
|
- |
|
| Needham Jeffrey |
Sr. VP Commercial Business Dev |
• – – |
2011-08-25 |
4 |
S |
$91.26 |
$819,953 |
D/D |
(8,985) |
3,585 |
|
- |
|
| Needham Jeffrey |
Sr. VP Commercial Business Dev |
• – – |
2011-08-25 |
4 |
OE |
$15.47 |
$786,278 |
D/D |
14,339 |
12,570 |
|
- |
|
| Needham Jeffrey |
Sr. VP Commercial Business Dev |
• – – |
2011-08-25 |
4 |
D |
$90.94 |
$160,873 |
D/D |
(1,769) |
3,585 |
|
- |
|
| Brown Judy L |
Executive VP & CFO |
• – – |
2011-08-25 |
4 |
D |
$90.94 |
$555,734 |
D/D |
(6,111) |
26,997 |
|
- |
|
| Brown Judy L |
Executive VP & CFO |
• – – |
2011-08-25 |
4 |
OE |
$90.94 |
$1,361,827 |
D/D |
14,975 |
29,357 |
|
- |
|
| Papa Joseph C |
President and CEOChairman |
• • – |
2011-08-25 |
4 |
D |
$90.94 |
$2,298,509 |
D/D |
(25,275) |
121,412 |
|
- |
|
| Papa Joseph C |
President and CEOChairman |
• • – |
2011-08-25 |
4 |
OE |
$90.94 |
$4,533,359 |
D/D |
49,850 |
131,171 |
|
- |
|
1400 Records found
|
|
Page 18 of 56 |
|
|
0.27 (0.9%) 
